INmune Bio Inc. to Report Year End 2025 Financial Results and Provide Corporate Update on Monday, March 30th.
Go back to INmune Bio Inc. to Report Year End 2025 Financial Results and Provide Corporate Update on Monday, March 30th.| (NASDAQ: INMB) | Delayed: 1.43 -0.02 (1.38%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $1.45 | 52 Week High | $ | |||
| Open | $1.41 | 52 Week Low | $ | |||
| Day High | $1.48 | P/E | N/A | |||
| Day Low | $1.35 | EPS | $ | |||
| Volume | 284,421 | |||||
| (NASDAQ: INMB) | Delayed: 1.43 -0.02 (1.38%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $1.45 | 52 Week High | $ | |||
| Open | $1.41 | 52 Week Low | $ | |||
| Day High | $1.48 | P/E | N/A | |||
| Day Low | $1.35 | EPS | $ | |||
| Volume | 284,421 | |||||

